CRISPR Therapeutics AG
CRSP News Today: Stay Updated with the Latest CRISPR Therapeutics AG News in Real Time
Find CRSP news now at Meyka AI. Stay informed with the latest CRISPR Therapeutics AG stocks updates, including price news, market analysis, and expert insights.
-12.45% intraday MMTX.SW MindMaze Therapeutics (SIX) 23 Feb 2026: monitor RSI
MMTX.SW stock down 12.45% intraday to CHF 0.907 on 23 Feb 2026; technicals and Meyka AI forecast included
Cantor Fitzgerald Keeps Overweight on PTC Therapeutics (PTCT) Feb 20 2026
Cantor Fitzgerald maintains Overweight on PTC Therapeutics; PTCT analyst rating updated Feb 20, 2026
RAIN.NS stock Rain Industries NSE INR 147.11 Feb 23 2026: earnings, 14.86% upside
RAIN.NS stock: Earnings due Feb 27, 2026. Current INR 147.11. Meyka forecast monthly INR 168.97.
Down 6.09% pre-market: MOLN.SW Molecular Partners AG (SIX) 23 Feb 2026, catalysts
Pre-market top loser MOLN.SW stock down 6.09% at CHF 3.94; pipeline catalysts and Meyka AI forecast show downside risk
TOVX Theriva Biologics AMEX pre-market +12% Feb 20 2026: Most active
TOVX stock jumps pre-market on SYN-020 license; volume surge and Meyka AI forecast show upside
1AD.AX stock falls 33% to A$0.003 on 20 Feb 2026 ASX: what traders must watch
1AD.AX stock fell 33% to A$0.003 on 20 Feb 2026; we explain drivers, valuation and Meyka AI forecast
OBSN.SW ObsEva S.A. pre-market SIX 20 Feb 2026: -76.92% to CHF0.001, high volume
OBSN.SW stock tumbles -76.92% pre-market on SIX to CHF0.001 with volume surge; quick technical and Meyka AI forecast inside
IHL.AX Incannex Healthcare ASX pre-market 20 Feb 2026: 61.36M shares active
Pre-market IHL.AX stock update: A$0.041, **61.36M** volume, analyst-grade outlook from Meyka AI
LOBE.CN Lobe Sciences (CNQ) up 37.5% to C$0.055 on 19 Feb 2026: key catalysts
LOBE.CN stock jumps 37.5% to C$0.055 on 19 Feb 2026; intraday drivers, Meyka grade and short-term forecast